Saquinavir trough concentration before and after switching NRTI to tenofovir in patients treated with once-daily saquinavir hard gel capsule/ritonavir 1600 mg/100 mg

Antivir Ther. 2004 Dec;9(6):1035-6.
No abstract available

Publication types

  • Clinical Trial
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenine / administration & dosage*
  • Adenine / analogs & derivatives*
  • Adenine / therapeutic use
  • Adult
  • Capsules
  • Drug Administration Schedule
  • Drug Therapy, Combination
  • Gels
  • HIV Infections / drug therapy*
  • HIV Protease Inhibitors / administration & dosage*
  • HIV Protease Inhibitors / pharmacokinetics
  • HIV Protease Inhibitors / therapeutic use
  • Humans
  • Organophosphonates / administration & dosage*
  • Organophosphonates / therapeutic use
  • Ritonavir / administration & dosage*
  • Ritonavir / therapeutic use
  • Saquinavir / administration & dosage
  • Saquinavir / pharmacokinetics*
  • Saquinavir / therapeutic use
  • Tenofovir

Substances

  • Capsules
  • Gels
  • HIV Protease Inhibitors
  • Organophosphonates
  • Tenofovir
  • Adenine
  • Saquinavir
  • Ritonavir